Institute of Chinese Materia Madica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Department of Pharmacy, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Pharmacol Res. 2021 Jan;163:105224. doi: 10.1016/j.phrs.2020.105224. Epub 2020 Sep 29.
Acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome (ARDS) as common life-threatening lung diseases with high mortality rates are mostly associated with acute and severe inflammation in lungs. With increasing in-depth studies of ALI/ARDS, significant breakthroughs have been made, however, there are still no effective pharmacological therapies for treatment of ALI/ARDS. Especially, the novel coronavirus pneumonia (COVID-19) is ravaging the globe, and causes severe respiratory distress syndrome. Therefore, developing new drugs for therapy of ALI/ARDS is in great demand, which might also be helpful for treatment of COVID-19. Natural compounds have always inspired drug development, and numerous natural products have shown potential therapeutic effects on ALI/ARDS. Therefore, this review focuses on the potential therapeutic effects of natural compounds on ALI and the underlying mechanisms. Overall, the review discusses 159 compounds and summarizes more than 400 references to present the protective effects of natural compounds against ALI and the underlying mechanism.
急性肺损伤(ALI)及其更严重的形式,急性呼吸窘迫综合征(ARDS)是常见的致命性肺部疾病,其死亡率较高,主要与肺部的急性和严重炎症有关。随着对 ALI/ARDS 的深入研究,已经取得了重大突破,但目前仍然没有有效的药理学治疗方法。特别是新型冠状病毒肺炎(COVID-19)正在肆虐全球,并导致严重的呼吸窘迫综合征。因此,迫切需要开发用于治疗 ALI/ARDS 的新药,这对于 COVID-19 的治疗也可能有帮助。天然化合物一直是药物开发的灵感来源,许多天然产物对 ALI/ARDS 显示出潜在的治疗效果。因此,本综述重点介绍了天然化合物对 ALI 的潜在治疗作用及其潜在机制。总的来说,该综述讨论了 159 种化合物,并总结了 400 多个参考文献,以阐述天然化合物对 ALI 的保护作用及其潜在机制。